Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02555657 |
|---|---|
| Brief Title: | Study of Single Agent Pembrolizumab (MK-3475) Versus Single Agent Chemotherapy for Metastatic Triple Negative Breast Cancer (MK-3475-119/KEYNOTE-119) |
| First Submitted : | September 18, 2015 |
| First Submitted that Met QC Criteria : | September 18, 2015 |
| First Posted : | September 21, 2015 (Estimate) |
| Results First Submitted : | March 27, 2020 |
| Results First Submitted that Met QC Criteria : | April 22, 2020 |
| Results First Posted : | May 4, 2020 |
| Last Update Submitted that Met QC Criteria : | November 9, 2021 |
| Last Update Posted : | December 10, 2021 |